PBGENE-PH1

N/A

Report date: 2024/12/02 15:11:02

Base Information

Drug NamePBGENE-PH1
Drug Alias NameHAO1 gene editing therapeuticPBGENE-PH1
ClassificationCell and gene therapy > Gene therapyBiologics > Protein drugs > Enzyme
Mechanisms of ActionHydroxyacid oxidase 1 inhibitors
TargetsHydroxyacid oxidase 1
Therapy Area/IndicationsHyperoxaluria, Primary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrecision Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrecision Biosciences Inc
Inactive CompaniesN/A
Active IndicationsHyperoxaluria, Primary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A